Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 177 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
This article has been cited by
1Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia
Xin Zhang,Dapeng Wan,Guosheng Yang,Qingping Peng,Xiaohui Wang
International Urology and Nephrology.2019;51(12)2273
2Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement
Rahul Valsaraj,Awadhesh Kumar Singh,Kalyan Kumar Gangopadhyay,Biswajit Ghoshdastidar,Ghanshyam Goyal,Masood Batin,Dibyendu Mukherjee,Upal Sengupta,Sanjay Chatterjee,Nilanjan Sengupta
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020;14(2)93
3Urate-lowering therapy for heart failure
O. V. Zhelyabina,M. S. Eliseev
Modern Rheumatology Journal.2019;13(3)109
4Some opportunities of using xanthine oxidase inhibitors
O. V. Zhelyabina,M. S. Eliseev
Modern Rheumatology Journal.2019;13(1)114
5Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue
Chun Hu,Xiaoyan Wu
International Urology and Nephrology.2019;51(12)2227
6Hyperuricemia, the heart, and the kidneys to treat or not to treat?
Tadej Petreski,Robert Ekart,Radovan Hojs,Sebastjan Bevc
Renal Failure.2020;42(1)978
  My Preferences